Skip to the page

Data / Form D filings / Cure Forward Corp.

Cure Forward Corp.: Form D filings

Cure Forward Corp., a technology company in Boston, MA, filed 6 Form D notices with the SEC between 2014 and 2017. The latest, on May 18, 2017, reports $4.5 million sold of a $4.5 million offering to 1 investor.

Find out what Cure Forward Corp. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
263 SUMMER STREET, 4TH FLOOR, Boston, MA, 02210
Phone
(650) 463-4052
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2012
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1624526

The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Other Technology: 8,166 rows, $161.66, or the new rows each week for $19.25 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 18, 2017Amendment$4,499,997$4,499,997$01Dec 16, 2016sec.gov
Dec 20, 2016New notice$3,999,997$3,999,997$01Dec 16, 2016sec.gov
Sep 29, 2016New notice$6,125,056$4,325,056$1,800,0001Sep 19, 2016sec.gov
Jun 22, 2015Amendment$4,000,000$4,000,000$01Oct 24, 2014sec.gov
Jun 22, 2015New notice$15,000,000$3,500,000$11,500,0001Jun 9, 2015sec.gov
Nov 14, 2014New notice$2,000,000$500,000$1,500,0001Oct 24, 2014sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Seth HarrisonDirector
Frank IngariExecutive Officer, Director
Aaron KantoffDirector
Stephanie PapesDirector
Steve HauExecutive Officer

Other technology companies in Massachusetts that filed recently

Every Form D from the week of May 15, 2017 · All recent filings in Massachusetts · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Cure Forward Corp. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.